𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis

✍ Scribed by SCHNIDER; BINDER; KITTLER; BIRNER; STARKEL; WOLFF; AUFF


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
120 KB
Volume
140
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Botulinum toxin type A for drooling in P
✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla

A randomized, double-blind, placebo-cont
✍ Dr. J. Jankovic; K. Schwartz; W. Clemence; A. Aswad; J. Mordaunt πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 585 KB

## Abstract Twenty‐five patients with hand tremor of 2 + (moderate) to 4 + (severe) on the tremor severity rating scale were randomized to receive either 50 U of botulinum toxin (BTX) type A (Allergan, Irvine, CA) or placebo injections into the wrist flexors and extensors of the dominant limb. If p

A randomized, double-blind, placebo-cont
✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 486 KB πŸ‘ 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des